menu
    • menu

    Company profile for Atossa Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Atossa Therapeutics is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. We believe our innovative therapies and delivery methods can transform breast cancer treatment– with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly dis...
    Atossa Therapeutics is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. We believe our innovative therapies and delivery methods can transform breast cancer treatment– with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Atossa TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1616 Eastlake Ave E, Suite 201, Seattle, WA 98102
    Telephone
    Telephone
    866-893-4927
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://atossatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atossa Therapeutics Presents (Z)-Endoxifen Updates at 2025 SABCS
    Atossa Therapeutics Presents (Z)-Endoxifen Updates at 2025 SABCS

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-presents-four-clinical-trial-updates-highlighting-z-endoxifen-research-at-the-2025-san-antonio-breast-cancer-symposium-302641613.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Atossa Pharma Gets FDA Rare Pediatric Disease Status For DMD
    Atossa Pharma Gets FDA Rare Pediatric Disease Status For DMD

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-receives-fda-rare-pediatric-disease-designation-for-z-endoxifen-for-duchenne-muscular-dystrophy-302638744.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Atossa Therapeutics Reports Q3 2025 Financials & Corporate Update
    Atossa Therapeutics Reports Q3 2025 Financials & Corporate Update

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-reports-third-quarter-2025-financial-results-and-provides-a-corporate-update-302612557.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Atossa Therapeutics Showcases RECAST™ DCIS Trial Progress
    Atossa Therapeutics Showcases RECAST™ DCIS Trial Progress

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-highlights-progress-in-recast-dcis-platform-trial-at-early-detection-research-conference-laura-esserman-md-mba-to-discuss-active-surveillance-strategy-and-novel-endocrine-agents-302589184.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Atossa Boosts Z-Endoxifen Global Patent Strategy With Israeli
    Atossa Boosts Z-Endoxifen Global Patent Strategy With Israeli

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-advances-global-patent-strategy-for-z-endoxifen-with-new-protection-in-israel-and-ongoing-renewals-302581338.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Atossa Therapeutics Focuses Evangeline Breast Cancer Trial
    Atossa Therapeutics Focuses Evangeline Breast Cancer Trial

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-streamlines-evangeline-breast-cancer-clinical-trial-to-prioritize-for-2026-nda-enabling-activities-302575551.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search